Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.48 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.44 |
| ▸ | RARB | P10826 | 2/20 | 0.44 |
| ▸ | RARA | P10276 | 1/20 | 0.44 |
| ▸ | RARG | P13631 | 1/20 | 0.44 |
| ▸ | ESR1 | P03372 | 2/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.44 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.44 |
| ▸ | TACR2 | P21452 | 2/20 | 0.44 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.44 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | SHBG | P04278 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.44 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13564077 | 0.98 | HTR2A (0.52) | HTR2ARARBRARARARGESR1 | |
| SCHEMBL7788951 | 0.98 | HTR2A (0.52) | HTR2ARARBRARARARGESR1 | |
| SCHEMBL7789300 | 0.98 | HTR2A (0.52) | HTR2ARARBRARARARGESR1 | |
| SCHEMBL12699223 | 0.94 | SKP2 (0.50) | HTR2ASKP2RARBRARARARG | |
| SCHEMBL14555727 | 0.88 | IGF1R (0.40) | HTR2ARARBRARARARG | |
| SCHEMBL29331986 | 0.88 | IGF1R (0.40) | HTR2ARARBRARARARG | |
| SCHEMBL8619701 | 0.86 | CNR1 (0.44) | SKP2TP53HSD17B10CA2LPL | |
| SCHEMBL7788862 | 0.86 | RARB (0.61) | HTR2ARARBRARARARGESR1 | |
| SCHEMBL13564089 | 0.85 | RARB (0.63) | HTR2ARARBRARARARGESR1 | |
| SCHEMBL19309401 | 0.84 | HTR2A (0.52) | HTR2ARARBRARARARGESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113684037-B | Liquid crystal compound containing dibenzothiophene structure and liquid crystal mixture containing liquid crystal compound | 晶美晟光电材料（南京）有限公司 | 2023-06-06 | — | — | CN | disclosed |
| CN-113684037-A | Liquid crystal compound containing dibenzothiophene structure and liquid crystal mixture containing liquid crystal compound | 晶美晟光电材料（南京）有限公司 | 2021-11-23 | — | — | CN | disclosed |
| CN-107794057-B | Negative liquid crystal compound, liquid crystal mixture and application thereof | 晶美晟光电材料（南京）有限公司 | 2021-03-23 | — | — | CN | disclosed |
| US-7018685-B2 | Fluorinated aromatic compounds and the use of the same in liquid crystal mixtures | MERCK PATENT GMBH (DE) | 2006-03-28 | — | — | US | disclosed |
| US-20040124399-A1 | Fluorinated aromatic compounds and the use of the same in liquid crystal mixtures | MERCK PATENT GMBH (DE) | 2004-07-01 | — | — | US | disclosed |
| EP-1349822-A1 | FLUORINATED AROMATIC COMPOUNDS AND THE USE OF THE SAME IN LIQUID CRYSTAL MIXTURES | CLARIANT INTERNATIONAL LTD. (CH) | 2003-10-08 | — | — | EP | disclosed |
| EP-1144546-A3 | FLUORINATED TERPHENYLS | QinetiQ Limited (GB) | 2002-08-28 | — | — | EP | disclosed |
| WO-2002055463-A1 | FLUORINATED AROMATIC COMPOUNDS AND THE USE OF THE SAME IN LIQUID CRYSTAL MIXTURES | CLARIANT INTERNATIONAL LTD. (CH) | 2002-07-18 | — | — | WO | disclosed |
| EP-0530338-B1 | ANISOTROPIC ORGANIC COMPOUNDS | QINETIQ LTD (GB) | 2002-05-02 | — | — | EP | disclosed |
| EP-1144546-A2 | FLUORINATED TERPHENYLS | QinetiQ Limited (GB) | 2001-10-17 | — | — | EP | disclosed |
| WO-2000004111-A2 | FLUORINATED TERPHENYLS | THE SECRETARY OF STATE FOR DEFENCE (GB) | 2000-01-27 | — | — | WO | disclosed |
| CN-1048018-C | Phosphonic diester derivative | OTSUKA PHARMA CO LTD (JP) | 2000-01-05 | — | — | CN | disclosed |
| US-5888421-A | LIQUID CRYSTALS | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (GB) | 1999-03-30 | — | — | US | disclosed |
| CN-1112365-A | Phosphonic diester derivatives | OTSUKA PHARMA CO LTD (JP) | 1995-11-22 | — | — | CN | disclosed |
| WO-1992016519-A2 | ANISOTROPIC ORGANIC COMPOUNDS | THE SECRETARY OF STATE FOR DEFENCE IN HER BRITANNIC MAJESTY'S GOVERNMENT OF THE UNITED KINGDOM OF GREAT BRITAIN AND NORTHERN IRELAND (GB) | 1992-10-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040124399-A1 | Fluorinated aromatic compounds and the use of the same in liquid crystal mixtures | AFF1, AFF2, FLI1 | HTR2A 1432/4885SKP2 1005/4885RARB 3047/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.